SYSTEMATIC REVIEW OF THE ONGOING CLINICAL TRIALS EVALUATING THE DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO MANAGE THE RESPIRATORY INFECTION CAUSED BY 2019 NOVEL CORONAVIRUS (2019-NCOV)

对正在进行的评估诊断和治疗干预措施以控制由 2019 新型冠状病毒 (2019-NCOV) 引起的呼吸道感染的临床试验进行系统评价

阅读：1
作者：Pericàs,J M,Hernandez-Meneses,M,Sheahan,T P,Quintana,E,Ambrosioni,J,Sandoval,E,Falces,C,Marcos,M A,Tuset,M,Vilella,A,Moreno,A,Miro,J M,Redkar,V,Redkar,S,Talwar,D,Redkar,S,Inamdar,M,Inamdar,A,Jeswani,D,Thacker,H,Kulkarni,S,Jumani,D,Deshpande,J,Deshpande,S,Rane,S,Jagtap,M,Khanolkar,D
期刊：European Heart Journal影响因子：35.600
时间：2020起止号：2020 Jun;157(6):A418
doi：10.1093/eurheartj/ehaa462研究方向： 炎症/感染、微生物学

Abstract

The COVID-19 pandemic has greatly impacted the daily clinical practice of cardiologists and cardiovascular surgeons. Preparedness of health workers and health services is crucial to tackle the enormous challenge posed by SARS-CoV-2 in wards, operating theatres, intensive care units, and interventionist laboratories. This Clinical Review provides an overview of COVID-19 and focuses on relevant aspects on prevention and management for specialists within the cardiovascular field.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。

2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。

4、投稿及合作请联系：info@biocloudy.com。